The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor - A randomized, double-blind, controlled study

Fisk, N. et al. (2001) The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor - A randomized, double-blind, controlled study. Acta Obstetricia et Gynecologica Scandinavica, 80(5), pp. 413-422.

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Cameron, Professor Alan
Authors: Fisk, N., Calder, A., Cameron, A., Elder, M., Fusi, L., Greer, I., Lamont, R., Mason, G., Owen, E., Steer, P., Tuffnell, D., Walker, J., Marsal, K., Ekman-Ordeberg, G., Gudmundsson, S., Ingemarsson, I., Lyrenas, S., Mattsson, L., Molin, A., Thomassen, P., Wennergren, M., and Weber, T.
College/School:College of Medical Veterinary and Life Sciences
Journal Name:Acta Obstetricia et Gynecologica Scandinavica

University Staff: Request a correction | Enlighten Editors: Update this record